|
| 37624957 | Assessment of Humoral Immune Responses to Repeated Influenza Vaccination in a Multiyear Cohort: A 5-Year Follow-up. | J Infect Dis | 2024 |
| 36285342 | H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans. | Influenza Other Respir Viruses | 2023 |
| 37741893 | A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages. | Sci Rep | 2023 |
| 37944489 | Putting the pieces together: Chimeric virus strategy decode Dengue virus 3 antibody responses. | Cell Host Microbe | 2023 |
| 37603310 | Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability. | Mol Pharm | 2023 |
| 37185989 | Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. | Commun Biol | 2023 |
| 37153624 | Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants. | Front Immunol | 2023 |
| 37012117 | Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses. | Vaccine | 2023 |
| 37033992 | Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG. | Front Immunol | 2023 |
| 37355452 | An Advax-CpG55.2â¿¢ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge. | Vaccine | 2023 |
| 36921600 | Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination. | Cell Rep Med | 2023 |
| 36720729 | Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine. | AAPS J | 2023 |
| 36851646 | Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. | Viruses | 2023 |
| 36851561 | Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines. | Viruses | 2023 |
| 36436743 | Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutinin. | Int J Pharm | 2023 |
| 36680282 | Urine Metabolome Dynamics Discriminate Influenza Vaccination Response. | Viruses | 2023 |
| 36680243 | Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses. | Viruses | 2023 |
| 36680224 | Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase. | Viruses | 2023 |
| 36708513 | Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor. | Cell Rep | 2023 |
| 34936487 | SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets. | J Virol | 2022 |
| 35653804 | Template-Assisted <i>De Novo</i> Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry. | J Proteome Res | 2022 |
| 35586986 | PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2. | mSphere | 2022 |
| 35479404 | Sex disparities in influenza: A multiscale network analysis. | iScience | 2022 |
| 35353486 | Development of an Intranasal Gel for the Delivery of a Broadly Acting Subunit Influenza Vaccine. | ACS Biomater Sci Eng | 2022 |
| 35842082 | Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccine. | Int J Pharm | 2022 |
| 35650631 | Altered transcriptional responses in the lungs of aged mice after influenza infection. | Immun Ageing | 2022 |
| 35704854 | Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine. | ACS Appl Mater Interfaces | 2022 |
| 35704783 | Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice. | Hum Vaccin Immunother | 2022 |
| 35702159 | α2,6-Sialylation is Upregulated in Severe COVID-19 Implicating the Complement Cascade. | medRxiv | 2022 |
| 35502639 | Next generation live-attenuated influenza vaccine platforms. | Expert Rev Vaccines | 2022 |
| 35641057 | High Prevalence of Both Previous Infection with SARS-CoV-2 and Persistent Symptoms. | J Am Board Fam Med | 2022 |
| 35697384 | The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines. | J Immunol | 2022 |
| 35757850 | Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway. | J Proteome Res | 2022 |
| 35632452 | The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination. | Vaccines (Basel) | 2022 |
| 35623484 | Multiplexed electrospray enables high throughput production of cGAMP microparticles to serve as an adjuvant for a broadly acting influenza vaccine. | Int J Pharm | 2022 |
| 35514207 | Evaluation of determinants of the serological response to the quadrivalent split-inactivated influenza vaccine. | Mol Syst Biol | 2022 |
| 35941152 | Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination. | Nat Commun | 2022 |
| 36366577 | Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study. | Viruses | 2022 |
| 36366544 | Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes. | Viruses | 2022 |
| 36197970 | Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans. | Sci Adv | 2022 |
| 36016202 | Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens. | Vaccines (Basel) | 2022 |
| 36219583 | α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade. | ACS Infect Dis | 2022 |
| 36051240 | Ferrets as a model for tuberculosis transmission. | Front Cell Infect Microbiol | 2022 |
| 35916534 | Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies. | J Virol | 2022 |
| 35289635 | Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019. | J Virol | 2022 |
| 35255298 | Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination. | Virology | 2022 |
| 34859584 | Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. | Influenza Other Respir Viruses | 2022 |
| 35100185 | Emotional Distress, Targeted Rejection, and Antibody Production After Influenza Vaccination in Adolescence. | Psychosom Med | 2022 |
| 35313572 | The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination. | bioRxiv | 2022 |
| 35241679 | Clinical validation of a multiplex PCR-based detection assay using saliva or nasopharyngeal samples for SARS-Cov-2, influenza A and B. | Sci Rep | 2022 |